Also R&D spend should soon give way to lower cost trial spend (mostly covered by Cannvalate) so cash burn should slow down. Then add oppies and oil sales imto the mix and next QTRs should be rosier
IHL Price at posting:
6.8¢ Sentiment: Buy Disclosure: Held